Aug 16, 2023 · Ceritinib is used to treat non-small cell lung cancer that has spread to other parts of the body. Ceritinib is used only if your cancer has a specific genetic marker. Your doctor will test you for this gene. Ceritinib may also be used for purposes not listed in this medication guide.

Mar 28, 2025 · Ceritinib is used in the treatment of pancreatic cancer, small cell lung cancer, liver cancer, kidney cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of colon and rectum, non-small cell lung cancer, soft tissue sarcoma, chronic idiopathic myelofibrosis and breast cancer.

Detailed Ceritinib dosage information for adults. Includes dosages for Non-Small Cell Lung Cancer; plus renal, liver and dialysis adjustments.

Ceritinib treats non-small cell lung cancer by stopping cancer cells from growing. This type of cancer originates in your lung tissues and grows slowly. You can take this medication by mouth with a glass of water and food as directed. Don’t take this medication with grapefruit juice.

Ceritinib is used to treat lung cancer. It is used for lung cancers that have a certain type of abnormal "ALK" gene. Ceritinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

May 1, 2023 · Ceritinib is a medication used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in adults. Ceritinib is a small molecule that selectively targets and inhibits the activity of abnormal ALK fusion proteins that cause lung cancer.

ZYKADIA® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test [see Dosage and Administration (2.1)].

Apr 3, 2024 · Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. …

Each capsule contains 150 mg ceritinib. Spexib is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.

Nov 8, 2024 · Discover comprehensive details about Ceritinib, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated...